Ingredient or product comparison
GHK-Cu for Skin Care: Peptide Comparison
GHK-Cu Copper delivery + collagen synthesis modulation 0.5–3% Limited (small human trials, strong in vitro data) Promising but not yet comparable to retinoid-level evidence. Best positioned as adjunct therapy. Matrixyl (Palmitoyl Pentapeptide) Stimulates colla
This source-based comparison does not add ratings or recommend a winner.
- GHK-Cu
- Copper delivery + collagen synthesis modulation
- 0.5–3%
- Limited (small human trials, strong in vitro data)
- Promising but not yet comparable to retinoid-level evidence. Best positioned as adjunct therapy.
- Matrixyl (Palmitoyl Pentapeptide)
- Stimulates collagen synthesis via TGF-beta pathway
- 3–8%
- Moderate (manufacturer-funded trials show improvements)
- More established than GHK-Cu but still lacks independent large-scale validation.
- Copper Tripeptide-1 (non-GHK)
- Copper delivery without GHK sequence
- 1–5%
- Minimal (largely anecdotal)
- Less studied than GHK-Cu. Mechanism overlaps but lacks the specific receptor binding GHK provides.
- Argireline (Acetyl Hexapeptide-8)
- Neurotransmitter inhibitor (topical botox alternative)
- 5–10%
- Weak (small trials, contested results)
- Mechanism is plausible but penetration to neuromuscular junction is questionable.